Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.665
-0.025 (-1.48%)
Apr 29, 2026, 10:16 AM EDT - Market open
Tempest Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 7.71 | 30.27 | 39.23 | 31.23 | 51.83 | Upgrade
|
| Cash & Short-Term Investments | 7.71 | 30.27 | 39.23 | 31.23 | 51.83 | Upgrade
|
| Cash Growth | -74.54% | -22.84% | 25.62% | -39.74% | 175.39% | Upgrade
|
| Prepaid Expenses | 0.2 | 0.64 | 0.7 | 0.7 | 0.95 | Upgrade
|
| Other Current Assets | 0.37 | 0.56 | 0.43 | 1.02 | 16.19 | Upgrade
|
| Total Current Assets | 8.27 | 31.47 | 40.36 | 32.95 | 68.96 | Upgrade
|
| Property, Plant & Equipment | 8.15 | 9.53 | 10.79 | 12.71 | 4.16 | Upgrade
|
| Other Long-Term Assets | 0.52 | 0.49 | 0.45 | 0.43 | 0.11 | Upgrade
|
| Total Assets | 16.93 | 41.49 | 51.6 | 46.09 | 73.24 | Upgrade
|
| Accounts Payable | 1.04 | 2.45 | 0.85 | 1.11 | 0.99 | Upgrade
|
| Accrued Expenses | 1.08 | 4.55 | 3.33 | 4.31 | 2.59 | Upgrade
|
| Current Portion of Long-Term Debt | - | 6.35 | 4.29 | - | - | Upgrade
|
| Current Portion of Leases | 1.19 | 0.87 | 0.95 | 1.41 | 1.44 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.45 | 15 | Upgrade
|
| Total Current Liabilities | 3.31 | 14.22 | 9.41 | 7.28 | 20.03 | Upgrade
|
| Long-Term Debt | - | - | 6.26 | 10.37 | 15.07 | Upgrade
|
| Long-Term Leases | 6.95 | 8.14 | 9.16 | 10.33 | 2.03 | Upgrade
|
| Total Liabilities | 10.26 | 22.36 | 24.84 | 27.98 | 37.12 | Upgrade
|
| Common Stock | 0.01 | 0 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 240.03 | 226.23 | 192.01 | 153.87 | 136.17 | Upgrade
|
| Retained Earnings | -233.37 | -207.11 | -165.26 | -135.77 | -100.06 | Upgrade
|
| Total Common Equity | 6.67 | 19.13 | 26.77 | 18.11 | 36.12 | Upgrade
|
| Shareholders' Equity | 6.67 | 19.13 | 26.77 | 18.11 | 36.12 | Upgrade
|
| Total Liabilities & Equity | 16.93 | 41.49 | 51.6 | 46.09 | 73.24 | Upgrade
|
| Total Debt | 8.14 | 15.37 | 20.66 | 22.11 | 18.54 | Upgrade
|
| Net Cash (Debt) | -0.43 | 14.9 | 18.57 | 9.12 | 33.29 | Upgrade
|
| Net Cash Growth | - | -19.74% | 103.70% | -72.62% | 103.24% | Upgrade
|
| Net Cash Per Share | -0.10 | 6.94 | 15.66 | 10.26 | 114.18 | Upgrade
|
| Filing Date Shares Outstanding | 14.34 | 3.5 | 1.71 | 0.81 | 0.55 | Upgrade
|
| Total Common Shares Outstanding | 4.93 | 3.38 | 1.7 | 0.81 | 0.53 | Upgrade
|
| Working Capital | 4.96 | 17.25 | 30.95 | 25.67 | 48.94 | Upgrade
|
| Book Value Per Share | 1.35 | 5.65 | 15.78 | 22.38 | 67.94 | Upgrade
|
| Tangible Book Value | 6.67 | 19.13 | 26.77 | 18.11 | 36.12 | Upgrade
|
| Tangible Book Value Per Share | 1.35 | 5.65 | 15.78 | 22.38 | 67.94 | Upgrade
|
| Machinery | 1.86 | 2.01 | 1.63 | 1.54 | 1.1 | Upgrade
|
| Leasehold Improvements | 0.2 | 0.2 | 0.24 | 0.88 | 0.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.